Global health care private equity deal value during 2024 was estimated at $115 billion, representing the second highest annual deal value since 2019 according to data compiled by Bain & Company, a global management consulting firm. Deal value in 2023 was estimated at $61 billion.

In total, five transactions during 2024 had a value exceeding $5 billion each, compared to two high value deals in 2023 and one in 2022. During 2024, the two largest value deals were in the biopharmaceutical sector; they involved Sanofi ($17.3 billion) and Catalent ($16.5 billion). The companies involved in the remaining high . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.